While it was not possible to detect PRAME-specific responses against the K562 HLA-A2+ cells or the 518A2 melanoma cells using the standard reporter, the CD2+CD226+ J76 PRAME TPR were stimulated by endogenously processed PRAME antigen expressed by these cells (Figure 3D). This evidence concerns the gene CD2 and melanoma.